Vo
lu
m
e
5,
M
ar
ch
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
EPIDEMIOLOGY AND PREVENTION OF BOTULISM
Butabayev Yakubjon Tuklibayevich
1
,
Yoqubov Davronbek
2
.
1.
Department of infectious diseases, Andijan State Medical Institute
2. 2nd year student of the Faculty of Medicine, Andijan State Medical Institute
Abstract:
Botulism is a rare but life-threatening paralytic illness caused by neurotoxins
from Clostridium botulinum. This article provides an overview of botulism, focusing on its
epidemiology and prevention. We summarize global incidence trends, risk factors, and
recent outbreaks to illustrate the public health significance of botulism. Finally, we discuss
strategies for prevention and control – including food safety measures, ongoing vaccination
research, and public health interventions – to reduce the burden of this disease [1].
Keywords:
Botulism, Clostridium botulinum, epidemiology, prevention, neurotoxin,
foodborne illness, wound botulism, infant botulism, botulinum toxin, food safety, public
health, vaccination, surveillance, outbreak prevention.
Introduction
Botulism is a rare but serious neuroparalytic disease caused by toxins produced by the
bacterium Clostridium botulinum . The toxin blocks nerve function, leading to muscle
paralysis that can progress to respiratory failure. Botulism is potentially fatal if not
recognized and treated promptly with antitoxin [2] . Fortunately, person-to-person
transmission does not occur, as botulism is acquired from toxin exposure (e.g. via food or
wounds) rather than spread from infected individuals . Nonetheless, even a single case is
treated as a public health emergency because it often signals a contaminated source that
could cause an outbreak . Rapid identification and response are critical due to the severity
of illness and the need to prevent additional cases [3].
Epidemiology
Global incidence: Botulism occurs worldwide but at very low rates. Many countries report
only a handful of cases per year. For example, the entire European Union (population ~450
million) reported just 82 confirmed cases in 2021, an overall notification rate of 0.02 cases
per 100,000 population . In contrast, the United States reports on the order of 150–250
cases annually, with 242 cases reported in 2018 . Incidence in most countries is well below
1 case per million people per year , though certain regions and populations have higher
exposure risks [4]. No clear increasing or decreasing global trend has been observed in
recent decades; botulism remains sporadic, with incidence largely tied to specific food
practices and behaviors.
Distribution of types: The prevalence of different botulism forms (foodborne, infant, wound,
etc.) varies by region. In the U.S., infant botulism (toxin produced in the infant gut after
spore ingestion) is the most common form – accounting for roughly 70% of U.S. cases .
Vo
lu
m
e
5,
M
ar
ch
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
From 2001–2017, the U.S. reported 1,862 infant cases, vastly exceeding the 326 foodborne
cases in that period . Wound botulism (toxin production in infected wounds) is also
relatively common in North America and the UK, partly due to injection drug use, whereas
classic foodborne botulism (ingesting preformed toxin in food) remains the dominant form
in many other countries. The UK, for instance, historically saw mostly foodborne cases, but
in recent years wound and infant botulism have become more frequent there . Mortality
rates for botulism have improved with modern care, but even with treatment the case-fatality
rate is around 5–10% (much higher if therapy is delayed or unavailable). Survivors may
require prolonged intensive care. These factors make botulism a persistent public health
concern despite its rarity.
Risk factors: Botulism can affect people of all ages, but certain exposures greatly increase
risk:
Foodborne botulism: Commonly linked to improperly canned, preserved, or fermented foods
that allow C. botulinum to grow and produce toxin . Home-canned vegetables, cured or
fermented meats, and seafood products prepared or stored under low-acid, anaerobic
conditions are frequent vehicles. For instance, in Alaska many cases have been traced to
traditional fermented fish and marine mammal products [5] . Consuming even a small
amount of toxin-contaminated food can cause illness, and the toxin has no taste or smell –
hence the adage “If in doubt, throw it out!”.
Wound botulism: Often associated with injection drug use. Injecting contaminated heroin
(especially black-tar heroin) or other substances can introduce C. botulinum spores into
anaerobic tissue, leading to toxin production in vivo. People who inject drugs are at much
higher risk of wound botulism than others . Traumatic injuries or surgical wounds
contaminated with soil can also, rarely, lead to botulism if not properly cleaned.
Infant botulism: Affects infants (mostly 2–4 months old) who ingest C. botulinum spores,
which then germinate and produce toxin in the baby’s intestines. A known source of spores
is honey, which has been implicated in a number of infant botulism cases [6] . For this
reason, parents are warned never to feed honey to infants under 1 year old. Environmental
dust and soil can also contain spores; infant botulism has no clear behavioral risk factors
aside from dietary exposures. (Notably, most infant cases occur sporadically and are not
linked to a specific food, making them hard to prevent beyond avoiding honey .)
Rare forms: Iatrogenic botulism (from medical or cosmetic use of botulinum toxin) and
adult intestinal colonization botulism are very uncommon. Iatrogenic cases have occurred
from overdose or improper injection of botulinum toxin for cosmetic treatments or pain
management. These are usually isolated incidents, though a notable outbreak resulted from
weight-loss injections in 2023 (see below). Adult intestinal colonization (akin to infant
botulism in adults with altered gut flora) is extremely rare.
Recent Outbreaks
Although botulism cases are usually isolated, outbreaks do occur, typically from a
contaminated batch of food or improper use of the toxin. Notable recent outbreaks include:
Vo
lu
m
e
5,
M
ar
ch
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Saudi Arabia, 2024 (Foodborne): In early 2024, the first recorded botulism outbreak in
Saudi Arabia was documented in Riyadh. It was traced to a contaminated mayonnaise used
by a popular local restaurant chain, which led to at least 8 confirmed cases of foodborne
botulism [7]. Patients ranged from adolescents to adults, and prompt clinical suspicion led
to diagnosis. This incident prompted authorities to strengthen food safety oversight in
restaurant food preparation.
France, 2023 (Foodborne): In September 2023, a botulism outbreak occurred in Bordeaux,
France, linked to homemade preserved sardines served at a single restaurant . The outbreak
took place during a period of high tourism (the Rugby World Cup), resulting in 15 cases
(one death) among patrons from multiple countries . Many patients required intensive care
[8]. Investigators found that the restaurant’s home-canning process for the sardines was
flawed, creating an anaerobic environment in which C. botulinum thrived. The event
underscored the dangers of improper canning even in commercial eateries and led to
international alerts via the WHO due to the globally dispersed patrons.
Europe (multi-country), 2023 (Iatrogenic): An unusual outbreak of iatrogenic botulism was
detected in March 2023, spanning Germany, Switzerland, Austria, and France. A total of 34
patients developed botulism after receiving intragastric botulinum toxin injections for
weight loss in Türkiye . The doses used in these injections were far higher than medically
recommended, causing systemic botulism in the patients. This travel-associated outbreak
was rapidly identified through Europe’s surveillance networks, and an international warning
was issued. It highlighted the risks of unregulated medical procedures and the need for
clinicians to consider botulism in patients presenting with paralysis after medical tourism [9].
United States, 2015 (Foodborne): Although not in the immediate past few years, a notable
outbreak occurred in Ohio in April 2015 – the largest U.S. botulism outbreak in nearly 40
years . It arose from a church potluck meal in which attendees consumed a potato salad
made with improperly home-canned potatoes . In total, 29 people were sickened and 1
died as a result of this outbreak. Investigators found the home canning had been done with a
boiling water bath instead of a pressure canner, which failed to kill the bacterial spores
[10] . This outbreak prompted renewed educational efforts about safe canning practices. It
also demonstrated the effectiveness of a rapid public health response: antitoxin from the
strategic national stockpile was delivered and administered swiftly, likely reducing the
fatality count.
These incidents illustrate how botulism can emerge in different contexts – from traditional
foods to trendy cosmetic/therapeutic procedures – and they reinforce the need for vigilance
in prevention efforts worldwide.
Preventive Measures
Many cases of botulism are preventable through proper food handling, public education, and
adherence to safety guidelines. Key strategies for botulism prevention and control include:
Food Safety Practices: Because foodborne botulism is the most preventable form, strict food
safety measures are paramount. Home canning of low-acid foods (vegetables, meats, fish,
etc.) should follow tested guidelines – including use of a pressure canner to achieve high
Vo
lu
m
e
5,
M
ar
ch
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
temperatures that destroy C. botulinum spores [11] . All jars and utensils should be
sterilized, and recipes from reputable sources (such as the USDA Home Canning Guide)
should be used. Adding sufficient acidity (vinegar) or salt to certain preserves can inhibit
bacterial growth. As an extra precaution, some high-risk home-canned foods can be boiled
for 10 minutes before tasting to inactivate any toxin . Consumers should never eat canned
foods that show spoilage (bulging lids, off-odors) and remember, botulinum toxin has no
smell or taste – if in doubt, throw it out . Beyond canning, other known sources of
botulism require care: oils infused with garlic or herbs should be refrigerated and used
within a few days , foil-wrapped baked potatoes should be kept hot or refrigerated
promptly (not left at room temperature in foil), and traditional fermentation of foods (such as
in Alaska) should be done in ways that limit anaerobic conditions [12] . Commercial food
processors and restaurants must likewise adhere to food safety regulations for canning and
storing foods; periodic training and inspections are essential to prevent outbreaks.
Public Awareness and Education: Targeted education can help high-risk groups avoid
botulism. For infant botulism, the well-known advice is to avoid giving honey to infants
under 1 year old . Health care providers and parenting resources consistently emphasize
this simple but important guideline. More broadly, because C. botulinum spores are
ubiquitous in soil and dust, most infant botulism cases are not linked to a specific avoidable
exposure [13] . Ongoing research into the gut factors that allow infant colonization may
inform future preventive measures, but for now, avoiding honey is the main
recommendation for infants. For wound botulism, prevention intersects with substance use
education and harm reduction. Individuals who inject drugs should be informed about the
risk of botulism from subcutaneous or intramuscular injection of contaminated drugs
(especially black tar heroin). Using only sterile, pharmaceutical-grade injection materials
(when possible) and seeking prompt medical care for any injection-site infections are
advised . Public health outreach programs in communities with injection drug use (e.g.
needle exchange programs) can incorporate warnings about wound botulism and how to
recognize its symptoms early. Additionally, basic wound care for all (cleaning and
disinfecting wounds, and watching for signs of infection) helps reduce the risk of wound
botulism from environmental spores.
Vaccination Research: Currently, no botulism vaccine is publicly available for routine use .
A pentavalent (five-type) toxoid vaccine was historically developed for laboratory workers
and the military, but it saw limited use due to concerns about incomplete efficacy and side
effects . However, vaccination remains a promising long-term preventive strategy,
especially given botulinum toxin’s potential use as a bioterrorism agent [14]. Recent
scientific advances are targeting safer and more effective vaccines. For example, researchers
have engineered detoxified botulinum toxoid fragments and genetic vaccines that stimulate
protective immunity without causing toxicity [15]. A tetravalent botulinum vaccine
(covering toxin types A, B, E, and F) was recently shown to induce strong protective
antibodies in mice and remained potent after long-term storage, indicating it could be a
stable and effective candidate . Other studies using viral vectors (like adenovirus-based
vaccines) have also demonstrated complete protection in animal models of botulism .
While these vaccines are not yet available for human use, ongoing research and clinical
trials may eventually yield an immunization to protect those at high risk (or the general
population in outbreak or bioterror scenarios). For now, prevention of botulism relies on
Vo
lu
m
e
5,
M
ar
ch
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
non-vaccine measures, but the progress in vaccine development is a hopeful sign for the
future.
Surveillance and Rapid Response: Because botulism is so rare, early detection of each case
is crucial to prevent larger outbreaks. Health professionals are encouraged to consider
botulism in patients with acute flaccid paralysis or cranial nerve palsies, especially if a
history of suspicious food intake or wound infection is present. Once a case is suspected, it
must be reported immediately to public health authorities (botulism is a nationally notifiable
disease in many countries). Swift epidemiological investigation can identify the source – for
instance, a batch of home-canned food – so that any remaining contaminated items can be
removed from consumption and contacts can be alerted [16]. As noted, even one botulism
case triggers a search for others; this approach has contained outbreaks in the past . Public
health agencies maintain contingency plans for botulism [17]. For example, the U.S. CDC
maintains a supply of botulinum antitoxin that can be rapidly deployed from a national
stockpile . In outbreak situations, antitoxin can be shipped and administered to patients
within hours, which markedly improves outcomes. Early antitoxin administration can
significantly reduce mortality and morbidity . Outbreak response also involves providing
ventilatory support to those with respiratory paralysis and monitoring others who may have
been exposed [18]. Communication is a key intervention: health departments often issue
alerts or press releases during botulism outbreaks to inform the public (e.g. warning about a
specific implicated food). International networks (like WHO’s INFOSAN and IHR
mechanisms, or the ECDC’s alert system) play an important role when outbreaks span
borders . In summary, a robust surveillance and response system doesn’t prevent botulism
from occurring, but it is critical in limiting the impact when a case or outbreak does occur
[19]. These public health interventions – from clinician awareness to antitoxin readiness –
collectively act as a safety net that catches cases quickly and prevents a single case from
becoming a mass outbreak [20].
Conclusion
Botulism remains a
public health concern
due to its extreme severity, even though it is
exceedingly rare in most parts of the world. The epidemiology of botulism shows a low
overall incidence, but certain patterns stand out: infant botulism is prominent in some
countries (like the U.S.), foodborne botulism occurs sporadically everywhere especially
where home preservation of food is common, and wound botulism is a risk in communities
affected by injection drug use. Notable outbreaks in recent years – whether from a mis-step
in food preparation or misuse of Botox for weight loss – serve as stark reminders that
vigilance is needed to prevent botulism.
Prevention efforts must center on educating food preparers (both at home and in industry)
about safe canning and preservation practices, ensuring strict food safety standards to avoid
contamination with botulinum spores. Simple measures like proper refrigeration, high-
temperature processing of canned foods, and discarding questionable foods can effectively
block the foodborne route of this illness. The public should be made aware of
recommendations such as avoiding giving honey to infants and seeking prompt care for
infected wounds. Meanwhile, the medical and cosmetic use of botulinum toxin requires
proper regulation and trained administration to avert avoidable iatrogenic cases.
Vo
lu
m
e
5,
M
ar
ch
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
On a broader level, maintaining strong surveillance and response systems is key to botulism
control. Rapid case identification, laboratory confirmation, and source investigation can
prevent additional cases. Stockpiling and swiftly delivering antitoxin, as well as providing
respiratory support, dramatically improves patient outcomes and survival when cases do
occur. International collaboration (through bodies like the WHO and ECDC) ensures that
information on outbreaks and best practices is shared globally.
Finally, continued research and development – particularly into vaccines and improved
antitoxins – offers hope for even better prevention in the future. While an effective
consumer vaccine for botulism is not yet available, progress in immunization science could
one day make routine protection feasible for high-risk groups or in crisis situations. In the
meantime, botulism prevention relies on the fundamentals of food safety, public awareness,
and prompt medical intervention. By adhering to these principles and remaining vigilant, we
can keep botulism at bay and mitigate its impact on public health.
References:
1.
Centers for Disease Control and Prevention (CDC). About Botulism – Key facts and
overview of botulism, its causes, and types. Atlanta, GA: CDC; updated April 18, 2024.
Available from: https://www.cdc.gov/botulism/about/index.html
2.
World Health Organization (WHO). Botulism – Fact Sheet. WHO Newsroom,
updated 2018. Key facts about botulism, including causes, symptoms, and prevention.
Available from: https://www.who.int/news-room/fact-sheets/detail/botulism
3.
McCarty CL, et al. “Notes from the Field: Large Outbreak of Botulism Associated
with a Church Potluck Meal — Ohio, 2015.” Morbidity and Mortality Weekly Report
(MMWR), vol. 64, no. 29, 2015, pp. 802–803. Centers for Disease Control and Prevention.
(Report on a 29-case foodborne botulism outbreak in Ohio)
4.
Yuldashevich, Oripov Shavkatjon. "LATENT TUBERCULOSIS: DEBUNKING
COMMON MISCONCEPTIONS." Ethiopian International Journal of Multidisciplinary
Research 12, no. 02 (2025): 295-297.
5.
Yuldashevich, Oripov Shavkatjon. "ANALYSIS OF THE MOST EFFECTIVE
METHODS OF TREATMENT OF ADENOVIRUS PNEUMONIA." In Russian-Uzbekistan
Conference, vol. 1, no. 1. 2024.
6.
Пулатов, М. Э., and Х. А. Гаффаров. "ЧАСТОТА ВЫЯВЛЕНИЯ АКТИВНОГО
ХРОНИЧЕСКОГО ГЕПАТИТА В СРЕДИ НОСИТЕЛЕЙ HbsAg." In Russian-
Uzbekistan Conference, vol. 1, no. 1. 2024.
7.
Камолдинов, М. М., and Х. А. Гаффаров. "Распространённость инфекций HCV
в различных группах детей и взрослых." Экономика и социум 1-1 (92) (2022): 464-467.
8.
Butabayev Yakubjon TuklibayevichDepartment of infectious diseases Andijan State
Medical Institute Uzbekistan, Andijan
9.
Tuklibayevich, Butabayev Yakubjon. "ETIOLOGY OF ALLERGIC OTITIS." In
Russian-Uzbekistan Conference, vol. 1, no. 1. 2024.
10.
Джураев, М. Г., and Я. Т. Бутабаев. "ИЗУЧЕНИЕ ЧАСТОТЫ ВЕНОЗНЫХ
ТРОМБОЭМБОЛИЙ У ГОСПИТАЛИЗИРОВАННЫХ ПАЦИЕНТОВ С COVID-19."
Экономика и социум 11-1 (102) (2022): 1213-1216.
11.
Nabijonovich, Kaxarov Abdukaxar. "THE MOST IMPORTANT FACTORS IN
THE
ETIOLOGY
OF
ALIMENTARY
TOXIC
ALEUKIA
AND
THEIR
CLASSIFICATION." In Russian-Uzbekistan Conference, vol. 1, no. 1. 2024.
Vo
lu
m
e
5,
M
ar
ch
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
12.
Nabijonovich, Kaxarov Abdukaxar. "CLASSIFICATION OF THE HUMAN
ORGANISM IMMUNE SYSTEM AND VARIOUS INFECTIOUS DISEASES FOUND IN
IT." Ethiopian International Journal of Multidisciplinary Research 10, no. 09 (2023): 418-
420.
13.
Nabijonovich, Kaxarov Abdukaxar. "ETIOLOGY, PATHOGENESIS AND
TREATMENT OF ADENOVIRUS INFECTION, WHICH IS NOW CONSIDERED A
COMMON AND CURRENT INFECTION." In Russian-Uzbekistan Conference, vol. 1, no.
1. 2024.
14.
Nabijonovich, Kaxarov Abdukaxar. "COMPLEMENTARY AND ALTERNATIVE
THERAPIES." Ethiopian International Journal of Multidisciplinary Research 10, no. 10
(2023): 236-239.
15.
Sayibovna, Tuxtanazarova Nargiza. "PREVENTION OF THE SPREAD OF
POLIOMYELITIS INFECTION, PATHOGENESIS AND STATISTICS ON THE
WORLD." Ethiopian International Journal of Multidisciplinary Research 10, no. 10 (2023):
30-34.
16.
Bakhodirovna, Mirzakarimova Dildora, and Abdukodirov Sherzodjon Taxirovich.
"CHARACTERISTICS OF RHINOVIRUS INFECTION." International journal of medical
sciences 4, no. 08 (2024): 55-59.
17.
Bayxanova, N., 2022. MONITORING OF OPPORTUNIST INFECTIONS IN
PATIENTS WITH HIV INFECTION. Экономика и социум, (2-2 (93)), pp.70-72.
18.
Каюмов, А.М., 2024, November. ОСОБЕННОСТИ ТЕЧЕНИЯ КОРИ У
ПРИВИТЫХ. In Russian-Uzbekistan Conference (Vol. 1, No. 1).
19.
Каюмов,
А.М.,
2024,
November.
ОСОБЕННОСТИ
ТЕЧЕНИЯ
КОРОНАВИРУСНОЙ ИНФЕКЦИИ НА ФОНЕ САХАРНОГО ДИАБЕТА. In Russian-
Uzbekistan Conference (Vol. 1, No. 1).
20.
Mutalibovich, Q.A., 2024. ENTEROVIRAL INFECTIONS: MODERN FEATURES.
Ethiopian International Journal of Multidisciplinary Research, 11(02), pp.199-200.
